THE COMPANY
Vision, team and technology to change the Dx industry
Broad patents backed by eight years of development expertise
Validation through multiple partnerships with industry, academia and government
Publications detailing LightDeck® technology in numerous applications
Strong management team and industry advisors
Our Next Event
July 30, 2019 - MBio Diagnostics featured in the Denver Business Journal, "How a Colorado biotech company aims to do what Theranos couldn't"
August 1, 2019 - MBio Diagnostics Announces Two Contracts for Sepsis Test Development
August 21, 2019 - Chris Myatt will be leading a short course on "Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization" at the Next Generation Dx Summit in Washington, DC
Our LightDeck® Technology
The MBio LightDeck® Platform
MBio’s patented LightDeck® technology system translates laboratory assays into on-the-spot, critical decisions in minutes.
Our LightDeck® platform incorporates low-cost, multiplexed cartridges with our flourescent readers and intuitive software, with the ability to measure more than 50 analytes in a single cartridge.
Our partners use LightDeck® to test key analytes across all applications and industries, measuring proteins, cells, nucleic acids and small molecules.
INDUSTRY OPPORTUNITY
MBio provides rapid, on-the-spot testing solutions for our global commercial partners
Proven demand for on-the-spot testing solutions in health care, veterinary, food and environmental applications
Our partners use LightDeck® to test key analytes across all applications and industries, measuring proteins, cells, nucleic acids and small molecules.